GlobeNewsWire
14 Jul 2026, 03:10 UTC · 2h ago
Erasca Announces Pricing of Upsized Public Offering of Common Stock
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
14 Jul 2026, 03:10 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Erasca is pricing an upsized public offering of 31,428,572 shares of common stock at $17.50 per share. — Public offerings typically cause short-term share price dilution and downward pressure on the stock.
-0.40The offering is expected to generate approximately $550 million in gross proceeds. — A significant capital infusion provides a substantial runway for R&D and clinical programs, reducing immediate bankruptcy risk.
+0.30Erasca has granted underwriters a 30-day option to purchase up to an additional 4,714,285 shares. — This creates potential for further dilution if the option is exercised.
-0.10Which stocks this story touches
Continue reading
6 related stories
Search tags
The company successfully priced an upsized public offering, raising approximately $550 million to fund R&D.
[a_to_b] Morgan Stanley is acting as a joint book-running manager for Erasca's public offering.
[a_to_b] Evercore is acting as a joint book-running manager for Erasca's public offering.
[a_to_b] J.P. Morgan is acting as a joint book-running manager for Erasca's public offering.
[a_to_b] Jefferies is acting as a joint book-running manager for Erasca's public offering.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
5h ago
